LadRx (CYTR) Short Interest Ratio & Short Volume

Short interest is the volume of LadRx shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 19,900 shares of CYTR short. Learn More on LadRx's current short interest.

LadRx saw a decline in short interest in the month of September. As of September 30th, there was short interest totaling 19,900 shares, a decline of 46.2% from the previous total of 37,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to LadRx: NKGen Biotech, Inc. (1.02%), AlloVir, Inc. (2.56%), Chromocell Therapeutics Co. (8.70%), Calidi Biotherapeutics, Inc. (1.23%), CEL-SCI Co. (5.24%), Omega Therapeutics, Inc. (26.99%), AIM ImmunoTech Inc. (414.92%), Fresh Tracks Therapeutics, Inc. (0.01%), Aptose Biosciences Inc. (3.30%), Organovo Holdings, Inc. (4.32%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($3.27 billion), Charter Communications, Inc. ($2.66 billion), TC Energy Corporation ($2.53 billion), Chesapeake Energy Co. ($1.86 billion), Coinbase Global, Inc. ($1.83 billion), Lucid Group, Inc. ($1.78 billion), T. Rowe Price Group, Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.69 billion), Zoom Communications, Inc. ($1.35 billion), and Williams-Sonoma, Inc. ($1.35 billion). View all of the most shorted stocks.

Short selling CYTR is an investing strategy that aims to generate trading profit from LadRx as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for LadRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTR, twice per month. The most recent reporting period available is September, 30 2022.